triacetin has been researched along with Leukemia in 1 studies
Triacetin: A triglyceride that is used as an antifungal agent.
triacetin : A triglyceride obtained by acetylation of the three hydroxy groups of glycerol. It has fungistatic properties (based on release of acetic acid) and has been used in the topical treatment of minor dermatophyte infections.
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Braun, H | 1 |
1 other study available for triacetin and Leukemia
Article | Year |
---|---|
[Results of animal experiments on radiosensitization in partial or whole-body radiation].
Topics: Alkaloids; Animals; Antifungal Agents; Antineoplastic Agents; Ascites; Colchicine; Demecolcine; Hydr | 1972 |